Top in endocrinology: ‘Green’ Mediterranean diet, building bone strength during menopause

A “green” Mediterranean diet may increase fasting ghrelin levels as well as improve insulin sensitivity and visceral adipose tissue regression, according to a recent study. It was the top story in endocrinology last week.

Another top story explored the benefit of monthly risedronate therapy on bone strength in postmenopausal women compared with a 12-month regimen of impact and resistance exercises.

Read these and more top stories in endocrinology below:

‘Green’ Mediterranean diet may boost fasting ghrelin, cardiometabolic health

Men assigned a “green” Mediterranean diet saw a twofold increase in fasting ghrelin level compared with a traditional Mediterranean diet, as well as an improvement in insulin sensitivity and visceral adipose tissue regression, data show. Read more.

Exercise builds bone strength during menopause

Postmenopausal women with low bone mass saw greater gains in spine bone mineral density and less bone turnover when assigned monthly risedronate therapy compared with a 12-month regimen of impact and resistance exercises, study data show. Read more.

Several beta cell receptors could explain link between COVID-19, new-onset diabetes

SARS-CoV-2 may use ACE2 or other enzymes as a receptor to infect beta cells, providing a possible explanation behind new-onset diabetes occurring in people with COVID-19, according to a speaker. Read more.

Tips for using diabetes apps in practice

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Beth Klos, RDN, LDN, CDCES, about the benefits of using apps for helping people with diabetes address challenges in self-management. Read more.

Identifying, treating pre-obesity can reduce mortality risk, improve health outcomes

Discussing weight gain and prescribing weight loss therapies or interventions for people with a BMI of 25 kg/m2 or greater could help reduce mortality risk and slow the progression of obesity, according to a speaker. Read more.